""

Downloads

AUSVAXSAFETY summary report 2020: Pregnant women infographic

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date: 
15 October 2021
Publication type: 
Infographic
Intended audience: 
General public
Description: 

For pregnant women who received the dTpa vaccine alone:

4,713 pregnant women responded to an SMS about their health a few days after their vaccination. 95% reported no adverse events. 5% reported any adverse event, including 0.2% who reported visiting a doctor or emergency department in the days after vaccination. The adverse events they reported were similar to the types of adverse events reported overall. 253 women reported one or more adverse events. The most commonly reported were injection site pain (124 reports), injection site swelling or redness (103 reports), tiredness (64 reports), headache (43 reports) and fever (21 reports). These symptoms are known to occur after vaccination. They are generally mild and short-lived. Adverse events were similar in pregnant women who had one vaccine and pregnant women who had both vaccines at the same time. Aboriginal and Torres Strait Islander pregnant women who received these vaccines had the same rates and types of adverse events as other pregnant women.

For pregnant women who received seasonal influenza and dTpa vaccines together:

1,128 pregnant women responded to an SMS about their health a few days after their vaccinations. 93% reported no adverse events. 7% reported any adverse event, including 0.4% who reported visiting a doctor or emergency department in the days after vaccination. The adverse events they reported were similar to the types of adverse events reported overall. 81 pregnant women reported one or more adverse events. The most commonly reported were injection site pain (31 reports), tiredness (27 reports), injection site swelling or redness (20 reports), fever (9 reports) and headache (9 reports). These symptoms are known to occur after vaccination. They are generally mild and short-lived. Adverse events were similar in pregnant women who had one vaccine and pregnant women who had both vaccines at the same time. Aboriginal and Torres Strait Islander pregnant women who received these vaccines had the same rates and types of adverse events as other pregnant women.

Vaccines given to pregnant women in 2020 are Afluria Quad, Fluarix Tetra, FluQuadri, Influvac Tetra or Vaxigrip Tetra (protects against influenza) and Adacel or Boostrix (protects against diphtheria, tetanus, whooping cough [dTpa]).

Part of a collection: